NASDAQ:GRAY Graybug Vision (GRAY) Stock Price, News & Analysis $0.63 0.00 (-0.17%) As of 05/22/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock About Graybug Vision Stock (NASDAQ:GRAY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Graybug Vision alerts:Sign Up Key Stats Today's Range$0.62▼$0.6550-Day Range$0.52▼$0.9052-Week Range$5.00▼$22.12Volume51,550 shsAverage Volume2,165 shsMarket Capitalization$988.00 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Graybug Vision, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for retinal diseases. The company’s proprietary Depot Technology Platform is designed to deliver sustained-release formulations of biologically active agents directly to the back of the eye, with the goal of reducing treatment burden and improving patient outcomes. Graybug’s lead product candidate, GB-102, is a long-acting formulation of sunitinib malate being investigated for the treatment of wet age-related macular degeneration (wet AMD). The company is also advancing GB-401, a sustained-release formulation of travoprost for the management of open-angle glaucoma. Graybug Vision’s clinical development program for GB-102 has included Phase I/II studies in patients with wet AMD, demonstrating a favorable safety profile and potential for extended dosing intervals compared to existing standards of care. The company has expanded its clinical footprint into multiple centers across the United States and has established collaborations with ophthalmology specialists to support ongoing and future trials. In parallel, preclinical and early clinical work on GB-401 aims to address unmet needs in glaucoma management by offering sustained intraocular pressure control without the need for daily eye drops. Founded with the mission of transforming ophthalmology through sustained-delivery technologies, Graybug Vision is headquartered in New York City. The company is led by President and Chief Executive Officer David R. Guyer, M.D., who brings over two decades of experience in ophthalmic drug development. Under his leadership, Graybug has assembled a team with deep expertise in pharmacology, formulation science, and clinical trial execution, positioning the company to advance its pipeline and explore additional indications for its Depot Technology Platform.AI Generated. May Contain Errors. Read More Receive GRAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Graybug Vision and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GRAY Stock News HeadlinesGrayscale Investments® Announces Rebalancing of Multi-Asset Funds for First Quarter 2026May 6, 2026 | globenewswire.comGrayscale Zcash Trust: A 20% ETF Conversion Arb OpportunityDecember 23, 2025 | seekingalpha.comJune 12: Elon Musk’s “Day-One Retirement Plan.”SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in before the IPO. Jeff Brown, who identified Bitcoin, Tesla, and Nvidia before gains as high as 52,400%, 2,150%, and 32,000% respectively, is sharing the details on how to claim a stake in Elon Musk's company before it hits public markets.May 26 at 1:00 AM | Brownstone Research (Ad)Grayscale Investments Files For IPO On Declining Results And Parent Legal CloudsNovember 17, 2025 | seekingalpha.comGENAI ANNOUNCES CHANGE OF MANAGEMENT AND APPOINTMENT OF PATRICK GRAY AS CEOJanuary 6, 2025 | prnewswire.comOppenheimer Sticks to Its Buy Rating for CalciMedica (CALC)November 1, 2024 | markets.businessinsider.comAge-Related Macular DegenerationOctober 23, 2024 | benzinga.comSeismic Therapeutic Appoints Julie Eastland as Independent Board DirectorSeptember 23, 2024 | finance.yahoo.comSee More Headlines GRAY Stock Analysis - Frequently Asked Questions How have GRAY shares performed this year? Graybug Vision's stock was trading at $5.85 on January 1st, 2026. Since then, GRAY shares have decreased by 89.2% and is now trading at $0.6289. How were Graybug Vision's earnings last quarter? Graybug Vision, Inc. (NASDAQ:GRAY) issued its quarterly earnings results on Thursday, November, 11th. The company reported ($5.32) EPS for the quarter, missing analysts' consensus estimates of ($5.18) by $0.14. When did Graybug Vision's stock split? Graybug Vision's stock reverse split before market open on Monday, March 20th 2023.The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Graybug Vision IPO? Graybug Vision (GRAY) raised $75 million in an IPO on Friday, September 25th 2020. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. SVB Leerink and Piper Sandler acted as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers. How do I buy shares of Graybug Vision? Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Graybug Vision own? Based on aggregate information from My MarketBeat watchlists, some other companies that Graybug Vision investors own include Tesla (TSLA), Plug Power (PLUG), NIO (NIO), Moderna (MRNA), Pinterest (PINS). Company Calendar Last Earnings11/11/2021Today5/26/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:GRAY CIK1534133 Webwww.graybug.com PhoneN/AFaxN/AEmployees27Year Founded2011Profitability EPS (Trailing Twelve Months)($24.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$35.60 million Net MarginsN/A Pretax MarginN/A Return on Equity-77.61% Return on Assets-71.34% Debt Debt-to-Equity RatioN/A Current Ratio10.73 Quick Ratio10.72 Sales & Book Value Annual Sales$426.96 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.67 per share Price / Book0.38Miscellaneous Outstanding Shares1,571,000Free Float20,250,000Market Cap$988.00 thousand OptionableNot Optionable Beta1.20 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:GRAY) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersOpportunity Forming in a U.S. Supply-Chain Weak Spot?America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...i2i Marketing Group, LLC | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graybug Vision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graybug Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
